2Korhonen S, Hippelainen M, Vanhala M. et al. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women : a controlled community-based study [ J ]. Fertil Steril,2003, 79:1327-1334. 被引量：1
3Faraj M, Sniderman A. and Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes [J]. J Lipid Res,2004,45:657-666. 被引量：1
4Cotreau MM, yon Mohke LL, Greenblatt DJ,et al. The influence of age and sex on the clearance of cytochrome 17450 3 A substrates [ J ]. Clin Pharmacokinet,2005,44 ( 1 ) :33-60. 被引量：1
5MitsuhiroY, Hidekl O, Masunori M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELLS): a randomised openlabel, blinded endpoint analysis [ J ]. Lancet ,2007,369:1090-1099. 被引量：1
6Harao N, Kikuo A, Hiroshige I, et al. Primary prevention of cardiovascular disease with pravastatin in Japan ( MEGA Study) : a prospective randomised controlled trial [ J ]. Lancet , 2006, 368 : 1155-1163. 被引量：1
7Margo D, Thomas P, Patrick M, et al. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome [ J ]. Diab Vasc Dis Res ,2006,3: 93-102. 被引量：1
9Jacques E. Rossouw, Ross L. Prentice, et al. Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause[ J]. JAMA, 2007,297 ( 13 ) : 1465-1477. 被引量：1
